Tirzepatide 10mg
Dual GIP/GLP-1 receptor co-agonist for comparative receptor selectivity and metabolic pathway research.
$100 minimum order. Free shipping over $300, otherwise $20. US domestic only. Zelle orders get an extra 5% off at checkout.
About this compound
Tirzepatide is a 39-amino acid peptide based on the GIP sequence, modified to co-activate both GIP and GLP-1 receptors with similar affinity. Its fatty diacid moiety supports albumin-mediated extended receptor engagement. Activates cAMP signaling in pancreatic islet cells and adipocytes. Dual incretin receptor pharmacology, comparative GIP vs GLP-1 signaling studies, metabolic pathway crosstalk research, and receptor selectivity assay panels.
| CAS | 2023788-19-2 |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Storage | −20°C, protect from light |
| Fill | 10mg per vial |
| Form | Lyophilized powder |
| Lab results | 23 on file · latest Apr 2026 |
Certificates of analysis
Results come from Janoshik Analytical Laboratory, an independent lab. Open any result to see the full report, or look up the test ID at janoshik.com.
| Date | Test | Batch | Test ID | Link |
|---|---|---|---|---|
| 17 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #221496 | View result |
| 17 Aug 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #221495 | View result |
| 17 Aug 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #212716 | View result |
| 17 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #195958 | View result |
| 1 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #206905 | View result |
| 1 Aug 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #206900 | View result |
| 1 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #206897 | View result |
| 1 Aug 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #206892 | View result |
| 8 Jul 2026 | TirzepatideIdentity & purity · Janoshik Analytical Laboratory | – | #195957 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #195388 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #195387 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #195376 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #195375 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #194262 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #193636 | View result |
| 8 Jul 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #193635 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #193629 | View result |
| 8 Jul 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #193628 | View result |
| Apr 2026 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #133565 | View result |
| Mar 2026 | TirzepatideHPLC identity & purity · Janoshik Analytical Laboratory | – | #111319 | View result |
| Nov 2025 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | Batch 5 | #85615 | View result |
| Aug 2025 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #72922 | View result |
| Prior | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #44778 | View result |
Results are from our supplier's published testing records. Dates show when each result was published. Each test covers the sample sent to the lab. See every compound on the lab results page.
More research compounds
Semaglutide
Long-acting GLP-1 receptor agonist analog for pancreatic β-cell signaling and incretin axis research.
Tirzepatide 30mg
High-concentration format of the dual GIP/GLP-1 co-agonist for extended assay series.
Retatrutide 10mg
Triple GLP-1/GIP/GCG receptor agonist for incretin crosstalk and glucagon pathway research.
Retatrutide 30mg
High-concentration triple GLP-1/GIP/GCG agonist for extended research series and multi-dose protocols.
For in vitro research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. By ordering you agree to our terms of service and research use agreement.